Fulton Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $460K | Buy |
5,090
+10
| +0.2% | +$838 | 0.01% | 507 |
|
|
2026
Q1 | $407K | Buy |
5,080
+54
| +1% | +$4.45K | 0.01% | 494 |
|
|
2025
Q4 | $428K | Sell |
5,026
-54
| -1% | -$4.43K | 0.01% | 479 |
|
|
2025
Q3 | $395K | Sell |
5,080
-416
| -8% | -$32.5K | 0.01% | 487 |
|
|
2025
Q2 | $430K | Buy |
5,496
+11
| +0.2% | +$820 | 0.02% | 459 |
|
|
2025
Q1 | $398K | Sell |
5,485
-26
| -0.5% | -$1.86K | 0.02% | 461 |
|
|
2024
Q4 | $408K | Sell |
5,511
-852
| -13% | -$59.6K | 0.02% | 468 |
|
|
2024
Q3 | $420K | Buy |
6,363
+141
| +2% | +$10.2K | 0.02% | 460 |
|
|
2024
Q2 | $575K | Sell |
6,222
-111
| -2% | -$9.83K | 0.02% | 362 |
|
|
2024
Q1 | $605K | Buy |
6,333
+13
| +0.2% | +$1.09K | 0.02% | 355 |
|
|
2023
Q4 | $482K | Buy |
6,320
+156
| +3% | +$10.9K | 0.02% | 378 |
|
|
2023
Q3 | $427K | Buy |
6,164
+1,389
| +29% | +$112K | 0.02% | 371 |
|
|
2023
Q2 | $450K | Sell |
4,775
-138
| -3% | -$12K | 0.02% | 357 |
|
|
2023
Q1 | $406K | Buy |
4,913
+797
| +19% | +$62.6K | 0.02% | 365 |
|
|
2022
Q4 | $307K | Sell |
4,116
-479
| -10% | -$36.9K | 0.02% | 403 |
|
|
2022
Q3 | $380K | Sell |
4,595
-74
| -2% | -$7.12K | 0.02% | 338 |
|
|
2022
Q2 | $444K | Sell |
4,669
-93
| -2% | -$9.63K | 0.02% | 316 |
|
|
2022
Q1 | $560K | Sell |
4,762
-22
| -0.5% | -$2.47K | 0.03% | 301 |
|
|
2021
Q4 | $620K | Hold |
4,784
| – | – | 0.03% | 299 |
|
|
2021
Q3 | $542K | Buy |
4,784
+147
| +3% | +$16.8K | 0.03% | 312 |
|
|
2021
Q2 | $481K | Sell |
4,637
-399
| -8% | -$37.6K | 0.02% | 313 |
|
|
2021
Q1 | $421K | Sell |
5,036
-1,093
| -18% | -$92.4K | 0.02% | 319 |
|
|
2020
Q4 | $559K | Sell |
6,129
-540
| -8% | -$44.8K | 0.03% | 274 |
|
|
2020
Q3 | $533K | Buy |
6,669
+624
| +10% | +$48.7K | 0.03% | 266 |
|
|
2020
Q2 | $418K | Sell |
6,045
-21,441
| -78% | -$1.52M | 0.03% | 279 |
|
|
2020
Q1 | $1.73M | Sell |
27,486
-4,611
| -14% | -$333K | 0.14% | 133 |
|
|
2019
Q4 | $2.5M | Sell |
32,097
-492
| -2% | -$38.4K | 0.16% | 122 |
|
|
2019
Q3 | $2.39M | Sell |
32,589
-594
| -2% | -$41.7K | 0.16% | 116 |
|
|
2019
Q2 | $2.04M | Sell |
33,183
-6,510
| -16% | -$394K | 0.14% | 129 |
|
|
2019
Q1 | $2.53M | Sell |
39,693
-564
| -1% | -$32.2K | 0.18% | 108 |
|
|
2018
Q4 | $2.06M | Sell |
40,257
-384
| -0.9% | -$19.4K | 0.16% | 117 |
|
|
2018
Q3 | $2.36M | Sell |
40,641
-1,356
| -3% | -$66.3K | 0.16% | 124 |
|
|
2018
Q2 | $2.04M | Sell |
41,997
-2,412
| -5% | -$113K | 0.14% | 124 |
|
|
2018
Q1 | $2.06M | Sell |
44,409
-312
| -0.7% | -$13.5K | 0.14% | 118 |
|
|
2017
Q4 | $1.68M | Sell |
44,721
-180
| -0.4% | -$6.61K | 0.12% | 138 |
|
|
2017
Q3 | $1.64M | Sell |
44,901
-2,649
| -6% | -$101K | 0.12% | 127 |
|
|
2017
Q2 | $1.87M | Sell |
47,550
-384
| -0.8% | -$14K | 0.15% | 111 |
|
|
2017
Q1 | $1.5M | Buy |
47,934
+4,908
| +11% | +$154K | 0.12% | 127 |
|
|
2016
Q4 | $1.34M | Sell |
43,026
-660
| -2% | -$21.4K | 0.12% | 137 |
|
|
2016
Q3 | $1.76M | Sell |
43,686
-7,554
| -15% | -$284K | 0.16% | 114 |
|
|
2016
Q2 | $1.7M | Sell |
51,240
-369
| -0.7% | -$12.6K | 0.17% | 118 |
|
|
2016
Q1 | $1.52M | Sell |
51,609
-10,317
| -17% | -$285K | 0.15% | 123 |
|
|
2015
Q4 | $1.63M | Buy |
61,926
+3,330
| +6% | +$86.5K | 0.17% | 116 |
|
|
2015
Q3 | $1.39M | Buy |
58,596
+25,032
| +75% | +$604K | 0.16% | 120 |
|
|
2015
Q2 | $796K | Buy |
33,564
+1,926
| +6% | +$43.5K | 0.08% | 182 |
|
|
2015
Q1 | $751K | Buy |
+31,638
| New | +$710K | 0.08% | 187 |
|
Other funds holding EW
Fulton Bank's EW Position: Q2 2026 in Review
Fulton Bank increased its Edwards Lifesciences (EW) stake by 0.2% in Q2 2026, buying an estimated $838 and bringing the position to 5,090 shares worth $460K. The position accounts for 0.01% of the portfolio, ranked #507.
Fulton Bank first reported a position in EW in Q1 2015 and has held it in 46 quarters since. The position peaked at $2.53M in Q1 2019. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Fulton Bank held 5,090 shares of Edwards Lifesciences worth $460K as of Q2 2026.
- Fulton Bank bought 10 Edwards Lifesciences shares in Q2 2026, an estimated $838.
- Edwards Lifesciences made up 0.01% of Fulton Bank's portfolio in Q2 2026, its #507 holding.
- Fulton Bank first reported a position in Edwards Lifesciences in Q1 2015 and has held it in 46 quarters since.
- Fulton Bank's Edwards Lifesciences position peaked at $2.53M in Q1 2019.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Fulton Bank's 13F filing for Q2 2026, filed 9 Jul 2026.